SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.841
EU - Europa 3.370
AS - Asia 1.839
SA - Sud America 62
AF - Africa 9
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.819
PL - Polonia 1.724
CN - Cina 729
SG - Singapore 680
IT - Italia 468
UA - Ucraina 404
TR - Turchia 295
DE - Germania 288
GB - Regno Unito 166
SE - Svezia 87
FI - Finlandia 84
BR - Brasile 55
ID - Indonesia 53
BE - Belgio 35
VN - Vietnam 34
RU - Federazione Russa 24
NL - Olanda 23
CA - Canada 20
FR - Francia 15
CZ - Repubblica Ceca 13
IN - India 11
AT - Austria 10
HK - Hong Kong 9
IR - Iran 9
LT - Lituania 8
RO - Romania 7
IE - Irlanda 6
AR - Argentina 4
ZA - Sudafrica 4
AU - Australia 3
BD - Bangladesh 3
IQ - Iraq 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
MX - Messico 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
VE - Venezuela 1
Totale 12.128
Salva come PNG Salva come JPEG
Città #
Warsaw 1.724
Fairfield 948
Woodbridge 759
Houston 549
Ashburn 453
Santa Clara 406
Jacksonville 401
Chandler 369
Seattle 367
Singapore 357
Ann Arbor 342
Wilmington 341
Cambridge 328
Izmir 237
Ferrara 183
Princeton 173
Beijing 163
Nanjing 161
San Diego 107
New York 101
Milan 64
Shanghai 62
Jakarta 52
Los Angeles 46
Boardman 42
Bologna 41
Nanchang 41
Shenyang 37
Hebei 36
Brussels 35
Dong Ket 34
Jiaxing 33
Tianjin 30
Changsha 28
Dearborn 27
Falls Church 24
London 23
Norwalk 22
Jinan 21
Mountain View 21
Helsinki 18
Orange 18
Rome 18
Redwood City 17
Falkenstein 15
San Mateo 15
Kunming 14
Modena 14
Auburn Hills 12
Brno 12
Des Moines 12
Munich 12
Ningbo 12
Ottawa 11
Taizhou 10
Ferrara di Monte Baldo 9
Toronto 9
Washington 9
Hong Kong 8
Nuremberg 8
San Bonifacio 8
Ardabil 7
Leawood 7
Phoenix 7
São Paulo 7
Changchun 6
Dublin 6
Frankfurt am Main 6
Hangzhou 6
Lanzhou 6
Monmouth Junction 6
Zhengzhou 6
Addison 5
Augusta 5
Bremen 5
Philadelphia 5
Verona 5
Andover 4
Council Bluffs 4
Dronten 4
Guangzhou 4
New Bedfont 4
Vienna 4
Belo Horizonte 3
Bucharest 3
Chicago 3
Easton 3
Fuzhou 3
Haikou 3
Lauterbourg 3
Novosibirsk 3
Prescot 3
Pune 3
Tappahannock 3
Amsterdam 2
Anzola 2
Arezzo 2
Berlin 2
Borgo Val di Taro 2
Brescia 2
Totale 9.613
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 276
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 265
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 239
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 223
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 222
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 219
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 209
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 207
null 183
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 176
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 168
null 167
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 165
Nanoparticles for delivery of a pharmacologically active agent 164
Recombinant herpes simplex virus and uses therefor 159
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 159
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 141
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 139
Transformation of hamster kidney cells by fragments of BK virus DNA 132
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 128
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 119
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 115
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 114
null 113
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 113
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 112
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 111
null 110
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 108
Episomal DNA of a BK virus variant in a human insulinoma 104
null 104
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 104
null 103
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 102
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 102
null 101
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 100
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 99
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 99
null 95
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 94
null 94
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 92
null 91
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 91
null 90
null 90
The HIV-1 regulatory genes tat and rev as targets for gene therapy 88
null 87
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 87
null 86
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 86
null 85
null 83
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 83
The tat gene and protein of the human immunodeficiency virus type 1. 83
null 81
null 79
null 79
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 77
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 76
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 76
Reexamination of the coding potential of the HTLV-1 pX region 76
null 75
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 75
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 74
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 73
null 72
Presenza del virus BK in sarcomi di Kaposi. 72
Transformation of Hamster kidney cells by a fragment of BK virus DNA containing the entire early region. 72
New BK virus episomal vector for complementary DNA expression in human cells 72
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 72
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation. 71
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 71
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 70
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 70
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 70
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 69
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 68
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 68
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 67
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 67
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 67
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 66
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 65
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 65
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 64
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 63
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 63
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 63
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 63
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 62
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 61
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 60
Oncogenicity of BK virus for immunosuppressed hamster 58
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 56
Studi sulle interrelazioni tra il virus BK e i tumori insulinari 55
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines 52
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine 52
Totale 10.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.063
Totale 67.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020820 0 0 0 0 0 0 0 0 238 332 159 91
2020/20211.767 165 150 142 156 111 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20251.594 91 70 240 100 332 225 114 108 314 0 0 0
Totale 12.373